4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)benzenemethanol,
El 737,
EL-737,
LY 031537,
LY-031537,
ractopamine,
ractopamine hydrochloride,
Ractopamine hydrochloride,
90274-24-1,
Ractopamine HCl,
4-(1-Hydroxy-2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)phenol hydrochloride,
rac Ractopamine Hydrochloride,
El737,
Benzenemethanol, 4-hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-, hydrochloride,
Topmax,
Paylean 9,
Optaflexx 45,
NCGC00164602-01,
LY 031537,
Optaflexx,
Paylean,
Topmax 9,
LYO31537,
Ractopamine hydrochloride [USAN:USP],
EC 415-170-5,
DSSTox_CID_26471,
DSSTox_RID_81643,
DSSTox_GSID_46471,
SCHEMBL350754,
CHEMBL2105358,
DTXSID1046471,
CTK3I7837,
Ractopamine hydrochloride (USAN),
JHGSLSLUFMZUMK-UHFFFAOYSA-N,
Pharmakon1600-01502332,
ractopamine hydrochloride, vetranal,
ractopamine hydrochloride (200 mg),
Tox21_112224,
KM2907,
LY O31537,
MFCD07781271,
NSC759638,
AKOS015961286,
API0004029,
CCG-213033,
NSC-759638,
AK122372,
AN-35078,
AS-13956,
SC-16063,
AX8150208,
CAS-90274-24-1,
TC-030810,
FT-0630973,
ST24042789,
SW220070-1,
D05691,
( inverted exclamation markA)-ractopamine-d3 hcl,
274R241,
Ractopamine hydrochloride, VETRANAL(TM), analytical standard,
4-[3-[[2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]butyl]phenol hydrochloride,
4-[3-[[2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]butyl]phenol;hydrochloride,
4-[3-[[2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]butyl]phenolhydrochloride,
4-[3-[2-Hydroxy-2-(4-hydroxyphenyl)-ethyl]aminobutyl]phenol hydrochloride,
4-[3-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]aminobutyl]phenol hydrochloride,
4-{3-[2-Hydroxy-2-(4-hydroxyphenyl)ethyl]aminobutylphenol hydrochloride,
4-Hydroxy-?-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]phenol hydrochloride,
Ractopamine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
(+-)-all-rac-p-Hydroxy-alpha-(((3-(p-hydroxyphenyl)-1-methylpropyl)amino)methyl)benzyl alcohol, hydrochloride,
(+/-)-4-(2-((3-(4-Hydroxyphenyl)-1-methylpropyl)amino)-1-hydroxyethyl)phenol hydrochloride,
4-Hydroxy-|A-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]benzenemethanol Hydrochloride,
benzenemethanol, 4-hydroxy-.alpha.-3-(4-hydroxyphenyl)-1-methylpropylaminomethyl-, hydrochloride,
Ractopamine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material,
Ractopaminehydrochloride,
UNII-309G9J93TP,
El 737,
Ractopamine hydrochloride [USAN],
309G9J93TP,
EL-737,
-4-[2-[[3- -1-methylpropyl]amino]-1-hydroxyethyl]phenolhydrochloride,
(+/-)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenolhydrochloride,
4-(1-Hydroxy-2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)phenolhydrochloride,
97825-25-7,
99095-19-9,
Bencenometanol, 4-hidroxi-alfa-[[[ 3-(4-hidroxifenil)-1-metilpropil] amino] metil]-, clorhidrato (1:1),
Benzenemethanol, 4-hydroxy-.alpha.-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]-, hydrochloride,
Draw
SDS
COA
